PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Teleflex Incorporated

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Teleflex Incorporated's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 6.4 times. Higher than 90% of Healthcare companies in United States.
  • Cash Cushion Ratio: Debt, after subtracting cash, equals 41% of its market value (net debt). Lower than 90% of Healthcare companies in United States.
  • Steadiness Ratio: Sales grew in 1 of the last 3 years; profit grew in 0 of 3. Less steady than 86% of Healthcare companies in United States.

Where $100 of sales goes

$87Operating costs$5.0Interest$45Net loss$3.0Paid as dividends

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

6.4×

Over the last 3 years its own operating cash covered its investment spending (capex) 6.4 times.

Higher than 90% of Healthcare companies in United States.

Cash Locked Ratio

$30

For every $100 of sales, $30 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $30 tied up three years earlier.

More money tied up than 66% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

1/3 · 0/3

Sales grew in 1 of the last 3 years; profit grew in 0 of 3.

Less steady than 86% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales fell 29%

Sales fell 29% in 3 years, so extra profit per extra sales cannot be measured.

Asset Productivity Ratio

-29% / +0%

In 3 years sales changed by -29% while total assets changed by +0%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

3.4×

Debt due within a year is covered 3.4 times by its yearly operating cash.

Higher than 77% of Healthcare companies in United States.

Cash Cushion Ratio

−41%

Debt, after subtracting cash, equals 41% of its market value (net debt).

Lower than 90% of Healthcare companies in United States.

Tangible Assets Ratio

45%

Of every $100 the company owns, $45 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 84% of Healthcare companies in United States.

Tangible Net Worth Ratio

Negative

Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.

Less tangible than 80% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

−6%

Share count fell 6% in 3 years (buybacks), so each share's slice of the company became larger.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Teleflex Incorporated made a loss over the last year. Teleflex Incorporated owes $0.57 for every $1 it owns. Teleflex Incorporated made a loss in the year to Dec 2025, after a profit the year before.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Teleflex Incorporated made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

1.99

The share price is 1.99 times Teleflex Incorporated's book value per share, lower than 59% of Healthcare companies in United States.

Market cap

$5.8 B

The total market value of all of Teleflex Incorporated's shares at today's price (share price × number of shares), larger than 86% of Healthcare companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$2.9 B

What Teleflex Incorporated would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$68.55

Net worth divided by the number of shares. The share price of $136.58 is 2.0 times this, which is the P/B above.

Return on equity (ROE)

-0.7%

Teleflex Incorporated lost 0.7% of its shareholders' money over the last year, higher than 75% of Healthcare companies in United States.

Owes vs Owns

0.57×

Teleflex Incorporated owes $0.57 for every $1 it owns (moderate), higher than 62% of Healthcare companies in United States.

Dividend yield

1.04%

Teleflex Incorporated pays 1.04% of its share price as dividends a year, lower than 52% of dividend-paying Healthcare companies in United States.

Revenue growth

+17%

Revenue rose 17% in the year to Dec 2025, and shrank 11% a year on average over 3 years.

Profit growth

Loss

Teleflex Incorporated made a loss in the year to Dec 2025, after a profit the year before.

Profit margin

-45.4%

Teleflex Incorporated lost $45 for every $100 of revenue.

Interest cover

2.6×

Teleflex Incorporated's operating profit covered its interest costs 2.6 times in the year to Dec 2025.

Cash vs debt

Net debt

Teleflex Incorporated had $2.3 B more debt than cash (net debt) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Teleflex Incorporated: $5.8 B ÷ $2.9 B (30 Jun 2026) = 2.0.

What is Teleflex Incorporated's return on equity?

Teleflex Incorporated lost 0.7% of its shareholders' money over the last year, higher than 75% of Healthcare companies in United States.

How much does Teleflex Incorporated owe compared with what it owns?

Teleflex Incorporated owes $0.57 for every $1 it owns (moderate), higher than 62% of Healthcare companies in United States.

Does Teleflex Incorporated pay a dividend?

Yes. Teleflex Incorporated pays 1.04% of its share price as dividends a year, lower than 52% of dividend-paying Healthcare companies in United States.

Is Teleflex Incorporated's revenue growing?

Revenue rose 17% in the year to Dec 2025, and shrank 11% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.